Interestingly, when 0.75 μg/μl of BDNF was chronically co-administered in vivo with R121919 (1 μg) into the ovBNST (Fig. 5a), the maladaptive affective behaviors induced by MS persisted. Here, BDNF is linked to myeloid sarcoma.